Sangamo BioSciences Logo
Sangamo BioSciences
  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Sangamo in the News
    • Contact Us
  • Product Pipeline
    • SB-728
    • SB-509
    • SB-313
    • Hemophilia
    • Rare Diseases
    • Other Indications
    • Clinical Trials
    • Publications
  • Technology Platform
    • ZFP Transcription Factors
    • ZFP Nucleases
    • Therapeutic Applications
    • Non-Therapeutic Applications
    • Publications
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQs
    • Contact Us
  • Careers
    • Job Opportunities
    • Benefits

ZFN technology for HIV/AIDS

Sangamo has a Phase 2 and two Phase 1/2 clinical trials to evaluate our ZFP Therapeutic® SB-728-T in T-cells for the treatment of HIV/AIDS Read More

2010 Form 10K

Our 2010 10K is now available for download. Download Now

Latest News

News articles are currently unavailable. Please check our investor section for more information.

Product Pipeline

View Complete Pipeline

© sangamo.com     Website design: Hane Chow Inc.
  • Terms Of Use
  • Privacy
  • Legal Notice